Leah Naghi, M.D.

Medical oncologist Leah Naghi, M.D., applies her interest in genetics to precision oncology for breast cancer patients, enjoying connecting with them and working to ensure they are partners in mapping out their individual treatment plans.

Dr. Naghi pursued her medical degree at the University of Southern California, then completed an internal medicine residency at New York’s Montefiore Medical Center. She came to City of Hope® for a fellowship in hematology and medical oncology, where she served as chief fellow. She has also completed City of Hope’s Intensive Course in Genetic Cancer Risk Assessment.

Her research includes investigations into hereditary cancer risk, including real world performance of genetic testing guidelines in multiethnic populations; mutation patterns in a large cohort of patients with hematologic malignancies; and treatment outcomes in breast cancer patients with actionable mutations. As part of her work in the lab led by the founding director of City of Hope's center for Precision Medicine, she presented research on enhanced screening practices of women after multiplex gene panel testing at the 2022 San Antonio Breast Cancer Symposium. She has also presented her research internationally.